Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
Ten male patients with chronic cocaine abuse received a single dose of the dopamine agonist apomorphine. Self-ratings of cocaine craving, depression, and anxiety decreased in response to apomorphine. Neuroendocrine response was consistent with central dopaminergic stimulation. Patients in the "craving" phase of the cocaine abuse cycle differed in behavioral but not neuroendocrine response to apomorphine from patients in the "crash" phase. Decrease in cocaine craving correlated with decrease in plasma homovanillic acid (pHVA). Total cocaine consumption correlated negatively with baseline prolactin and pHVA levels and inversely with peak change in prolactin following apomorphine. Patients had blunted neuroendocrine response to apomorphine in comparison to historical normal controls. Implications for the "dopamine" hypothesis of cocaine abuse are discussed.
Hollander
E
E
N.Y.S. Psychiatric Institute, NY 10032.
Nunes
E
E
DeCaria
C M
CM
Quitkin
F M
FM
Cooper
T
T
Wager
S
S
Klein
D F
DF
D000328:Adult; D001007:Anxiety / Q000097:blood; D001058:Apomorphine; D001288:Attention / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D003042:Cocaine / Q000009:adverse effects; D004298:Dopamine / Q000097:blood*; D006719:Homovanillic Acid / Q000097:blood; D006801:Humans; D008297:Male; D011388:Prolactin / Q000097:blood*; D011954:Receptors, Dopamine / Q000187:drug effects*; D013375:Substance Withdrawal Syndrome / Q000097:blood; D019966:Substance-Related Disorders / Q000097:blood*
D011954:Receptors, Dopamine; D011388:Prolactin; D003042:Cocaine; D001058:Apomorphine; D004298:Dopamine; D006719:Homovanillic Acid